LC-MS/MS of human T-ALL following 12h of ATR inhibition

ABSTRACT: Quantitative proteomic and phosphoproteomic analysis of the human T-ALL cell line, CCRF CEM, following 12 hours of ATR inhibiton using the Vertex drug, VE-822.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): T Cell, Blood

DISEASE(S): Acute Leukemia

SUBMITTER: Joseph Capri  

LAB HEAD: Caius Radu

PROVIDER: PXD006702 | Pride | 2017-07-31

REPOSITORIES: Pride